{"quote": {"result": [{"language": "en-US", "region": "US", "quoteType": "EQUITY", "typeDisp": "Equity", "quoteSourceName": "Delayed Quote", "triggerable": false, "customPriceAlertConfidence": "LOW", "currency": "EUR", "exchange": "FRA", "shortName": "AMICUS THERAPEUTICS INC.", "longName": "Amicus Therapeutics, Inc.", "messageBoardId": "finmb_7009878", "exchangeTimezoneName": "Europe/Berlin", "exchangeTimezoneShortName": "CEST", "gmtOffSetMilliseconds": 7200000, "market": "dr_market", "esgPopulated": false, "regularMarketChangePercent": 1.9047601, "regularMarketPrice": 10.7, "marketState": "REGULAR", "fiftyTwoWeekHighChangePercent": -0.15052398, "fiftyTwoWeekLow": 6.819, "fiftyTwoWeekHigh": 12.596, "earningsTimestamp": 1683721800, "earningsTimestampStart": 1690979400, "earningsTimestampEnd": 1691411400, "trailingAnnualDividendRate": 0.0, "trailingAnnualDividendYield": 0.0, "epsTrailingTwelveMonths": -0.77, "epsForward": -0.51, "epsCurrentYear": -0.82, "priceEpsCurrentYear": -13.04878, "sharesOutstanding": 283337984, "bookValue": 0.438, "fiftyDayAverage": 10.71444, "fiftyDayAverageChange": -0.0144405365, "fiftyDayAverageChangePercent": -0.0013477639, "twoHundredDayAverage": 11.019685, "twoHundredDayAverageChange": -0.31968498, "twoHundredDayAverageChangePercent": -0.029010355, "marketCap": 3031716352, "forwardPE": -20.980392, "priceToBook": 24.429224, "sourceInterval": 15, "exchangeDataDelayedBy": 15, "averageAnalystRating": "2.4 - Buy", "tradeable": false, "cryptoTradeable": false, "priceHint": 2, "regularMarketChange": 0.19999981, "regularMarketTime": 1683871252, "regularMarketDayHigh": 10.7, "regularMarketDayRange": "10.7 - 10.7", "regularMarketDayLow": 10.7, "regularMarketVolume": 97, "regularMarketPreviousClose": 10.5, "bid": 10.4, "ask": 10.5, "bidSize": 500, "askSize": 500, "fullExchangeName": "Frankfurt", "financialCurrency": "USD", "regularMarketOpen": 10.7, "averageDailyVolume3Month": 0, "averageDailyVolume10Day": 0, "fiftyTwoWeekLowChange": 3.881, "fiftyTwoWeekLowChangePercent": 0.5691451, "fiftyTwoWeekRange": "6.819 - 12.596", "fiftyTwoWeekHighChange": -1.8959999, "firstTradeDateMilliseconds": 1180936800000, "symbol": "AM6.F"}], "error": null}, "summary": {"result": [{"assetProfile": {"address1": "3675 Market Street", "city": "Philadelphia", "state": "PA", "zip": "19104", "country": "United States", "phone": "215 921 7600", "fax": "215 921 7900", "website": "https://amicusrx.com", "industry": "Biotechnology", "industryDisp": "Biotechnology", "sector": "Healthcare", "longBusinessSummary": "Amicus Therapeutics, Inc., a biotechnology company, focuses on discovering, developing, and delivering medicines for rare diseases. Its commercial product and product candidates include Galafold, an oral precision medicine for the treatment of adults with a confirmed diagnosis of Fabry disease and an amenable galactosidase alpha gene variant based on in vitro assay data. The company also develops AT-GAA, a novel treatment paradigm for Pompe disease; and enzyme replacement therapies for Pompe diseases. It has collaboration and license agreements with Nationwide Children's Hospital; University of Pennsylvania; and GlaxoSmithKline. The company was incorporated in 2002 and is headquartered in Philadelphia, Pennsylvania.", "fullTimeEmployees": 484, "companyOfficers": [{"maxAge": 1, "name": "Mr. John F. Crowley", "age": 55, "title": "Exec. Chairman", "yearBorn": 1967, "fiscalYear": 2022, "totalPay": {"raw": 1878804, "fmt": "1.88M", "longFmt": "1,878,804"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 3203616, "fmt": "3.2M", "longFmt": "3,203,616"}}, {"maxAge": 1, "name": "Mr. Bradley L. Campbell M.B.A.", "age": 46, "title": "CEO, Pres & Director", "yearBorn": 1976, "fiscalYear": 2022, "totalPay": {"raw": 984087, "fmt": "984.09k", "longFmt": "984,087"}, "exercisedValue": {"raw": 461214, "fmt": "461.21k", "longFmt": "461,214"}, "unexercisedValue": {"raw": 3854297, "fmt": "3.85M", "longFmt": "3,854,297"}}, {"maxAge": 1, "name": "Ms. Daphne E. Quimi CPA, M.B.A.", "age": 56, "title": "Chief Financial Officer", "yearBorn": 1966, "fiscalYear": 2022, "totalPay": {"raw": 748401, "fmt": "748.4k", "longFmt": "748,401"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1241180, "fmt": "1.24M", "longFmt": "1,241,180"}}, {"maxAge": 1, "name": "Ms. Ellen S. Rosenberg", "age": 59, "title": "Chief Legal Officer & Corp. Sec.", "yearBorn": 1963, "fiscalYear": 2022, "totalPay": {"raw": 733943, "fmt": "733.94k", "longFmt": "733,943"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 1730125, "fmt": "1.73M", "longFmt": "1,730,125"}}, {"maxAge": 1, "name": "Mr. David M. Clark", "age": 47, "title": "Chief People Officer", "yearBorn": 1975, "fiscalYear": 2022, "totalPay": {"raw": 701389, "fmt": "701.39k", "longFmt": "701,389"}, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 341111, "fmt": "341.11k", "longFmt": "341,111"}}, {"maxAge": 1, "name": "Dr. Jeffrey P. Castelli", "age": 50, "title": "Chief Devel. Officer", "yearBorn": 1972, "fiscalYear": 2022, "totalPay": {"raw": 709644, "fmt": "709.64k", "longFmt": "709,644"}, "exercisedValue": {"raw": 88607, "fmt": "88.61k", "longFmt": "88,607"}, "unexercisedValue": {"raw": 543184, "fmt": "543.18k", "longFmt": "543,184"}}, {"maxAge": 1, "name": "Ms. Samantha  Prout", "age": 44, "title": "VP, Global Controller & Principal Accounting Officer", "yearBorn": 1978, "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Dr. Jill  Weimer Ph.D.", "title": "Chief Science Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Andrew  Faughnan", "title": "Sr. Director of Investor Relations", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}, {"maxAge": 1, "name": "Mr. Patrik S. Florencio Esq.", "title": "Global Chief Compliance & Risk Officer", "exercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}, "unexercisedValue": {"raw": 0, "fmt": null, "longFmt": "0"}}], "auditRisk": 8, "boardRisk": 5, "compensationRisk": 5, "shareHolderRightsRisk": 7, "overallRisk": 6, "governanceEpochDate": 1682899200, "compensationAsOfEpochDate": 1672444800, "maxAge": 86400}}], "error": null}}